*To the editor,*

We read with great interest the article by Dr. Galloway JB and colleagues recently published in the *Journal of Infection* entitled "A clinical risk score to identify patients with COVID-19 at high risk of critical care admission or death: An observational cohort study".[@bib0001] Early identification of patients with high-risk of poor prognosis may facilitate the provision of timely supportive treatment in advance and reduce the mortality of patients. In this study, the authors identified several comorbidities as risk factors of worse outcomes of COVID-19 patients, including diabetes, hypertension, and chronic lung disease. However, little is known about the impact of previous surgery on COVID-19. Herein, we evaluated whether COVID-19 patients with previous surgery are at high-risk of critical illness.

We conducted a multicenter study focusing on the clinical characteristics of COVID-19 patients with previous surgery in six designated hospitals in the Hubei and Guangdong provinces, China. COVID-19 was diagnosed according to the WHO interim guidance. 461 patients with COVID-19 that hospitalized from January 1 to March 31, 2020 were enrolled. We collected demographics, comorbidities, laboratory variables, and chest CT images from medical records. We defined the severity of COVID-19 according to the newest COVID-19 guidelines of China[@bib0002] and the guidelines of American Thoracic Society for community-acquired pneumonia.[@bib0003] Critical illness is defined as meeting at least one of the following criteria: respiratory failure requiring mechanical ventilation, shock, intensive care unit (ICU) admission, or death. According to surgical sites, previous surgeries were categorized into cardiovascular surgery, skeletal surgery, urogenital surgery, head and neck surgery, gastrointestinal surgery and others. Baseline features were compared between patients with and without previous surgery. To identify risk factors for critical illness, baseline variables with *p* \< 0.10 in univariable analysis were entered into multivariate logistic regression. Time from diagnosis of COVID-19 to death was explored using Kaplan-Meier survival analysis. Considering in-hospital death is competing risk of ICU admission, time from diagnosis of COVID-19 to ICU admission was analyzed by a competing-risk model. Our institutional ethics review board approved the study and waived the need for informed consent.

In total, 47 (10.2%) COVID-19 patients with previous surgery. Gastrointestinal surgery was the most frequent surgery type (19/47, 40.4%), followed by cardiovascular surgery (11/47, 23.4%), urogenital surgery (10/47, 21.3%), skeletal surgery (7/47, 14.9%), and head and neck surgery (6/47, 12.8%). COVID-19 patients with previous surgery had obviously worse outcomes (*p* \< 0.001). Compared with patients who had no previous surgery, patients had previous surgery were older (*p* \< 0.001), had higher rate of hypertension (*p* = 0.039), coronary heart disease (*p* = 0.002), diabetes (*p* = 0.017), and chronic lung disease (*p* = 0.020), lower lymphocyte (*p* = 0.001) and albumin (*p* = 0.022), and higher aspartate aminotransferase (*p* = 0.013) and high-sensitivity C-reactive protein (*p* = 0.011) (Supplementary Table 1). Among various surgery types, only previous cardiovascular surgery was an independent risk factors of developing critical illness (odds ratio \[OR\] = 12.0, 95% CI: 2.1--69.6, *p* = 0.006) ([Table 1](#tbl0001){ref-type="table"} ). After adjusting for age, sex, and other comorbidities, the OR was 11.6 (95% CI: 2.7--49.6, *p* = 0.001). Patients with previous cardiovascular surgery had significantly worse survival (*p* = 0.001) and higher cumulative incidence of ICU admission (*p* \< 0.001) than those patients without previous cardiovascular surgery (Supplementary Fig. 1).Table 1Identification of risk factors of critical illness in COVID-19 patients using univariable and multivariable logistic regression.Table 1UnivariableMultivariableOR (95% CI)*P* valueOR (95% CI)*P* value*Age (years)*1.075 (1.054, 1.096)\<0.0011.053 (1.022, 1.085)0.001*Male*1.728 (1.031, 2.896)0.0381.178 (0.493, 2.814)0.713*Comorbidities*Hypertension3.650 (2.133, 6.244)\<0.0011.966 (0.831, 4.648)0.124Coronary heart disease2.992 (1.271, 7.043)0.0120.382 (0.096, 1.526)0.173Diabetes3.804 (1.981, 7.302)\<0.0011.205 (0.404, 3.590)0.738Chronic liver diseases1.054 (0.296, 3.759)0.935Chronic lung diseases1.970 (0.839, 4.626)0.119*Types of previous surgery*Gastrointestinal surgery2.372 (0.873, 6.446)0.0901.287 (0.297, 5.567)0.736Head and neck surgery5.067 (1.003, 25.586)0.0505.785 (0.735, 45.534)0.095Urogenital surgery2.149 (0.543, 8.498)0.276Skeletal surgery6.847 (1.501, 31.228)0.0131.946 (0.205, 18.438)0.562Cardiovascular surgery9.342 (2.665, 32.747)\<0.00111.998 (2.068, 69.612)0.006Others---0.999*Laboratory findings*WBC (× 10^9^/L)1.223 (1.122, 1.334)\<0.0011.015 (0.458, 2.252)0.971Neutrophil (× 10^9^/L)1.305 (1.190, 1.432)\<0.0011.136 (0.505, 2.552)0.758Lymphocyte (× 10^9^/L)0.129 (0.067, 0.248)\<0.0010.982 (0.288, 3.342)0.977LDH (U/L)1.010 (1.007, 1.012)\<0.0011.009 (1.005, 1.013)\<0.001Hemoglobin (g/L)1.002 (0.989, 1.015)0.812Platelet (g/L)0.994 (0.990, 0.997)0.0010.994 (0.988, 1.000)0.051Albumin (g/L)0.827 (0.783, 0.873)\<0.0011.039 (0.929, 1.161)0.507AST (U/L)1.029 (1.017, 1.041)\<0.0011.002 (0.984, 1.020)0.851ALT (U/L)1.004 (0.996, 1.011)0.344DBIL (μmol/L)1.176 (1.078, 1.284)\<0.0011.151 (1.004, 1.319)0.043IBIL (μmol/L)0.932 (0.873, 0.994)0.0320.893 (0.771, 1.035)0.133TBIL (μmol/L)1.016 (0.986, 1.046)0.299APTT (s)1.017 (0.979, 1.058)0.381PT (s)1.038 (0.996, 1.081)0.0801.038 (1.000, 1.077)0.053[d]{.smallcaps}-dimer (μg/ml)1.002 (0.999, 1.004)0.285Creatinine (μmol/L)1.023 (1.012, 1.034)\<0.0011.006 (0.994, 1.018)0.325hs-CRP (mg/L)1.013 (1.007, 1.019)\<0.0010.991 (0.981, 1.000)0.062Procalcitonin (ng/ml)1.124 (1.036, 1.220)0.0051.043 (0.929, 1.173)0.475Urea nitrogen (mmol/L)1.316 (1.206, 1.435)\<0.0011.191 (1.056, 1.343)0.005FBG (mmol/L)0.953 (0.887, 1.024)0.188*CT score*0.953 (0.887, 1.024)0.188[^2]

To our best of knowledge, this is the first study that showed that patients with previous cardiovascular surgery instead of other surgeries significantly increase the risk of developing critical illness among patients with COVID-19.

Close attention should be paid to this population. High-level monitoring and aggressive treatment may be necessary to improve the outcomes of these patients.
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Supplementary material associated with this article can be found, in the online version, at [doi:10.1016/j.jinf.2020.08.012](https://doi.org/10.1016/j.jinf.2020.08.012){#interref0001}.

[^1]: Bin Zhang and Shuyi Liu contributed equally to this work.

[^2]: *Abbreviations:* OR**,** odds ratio; CI: confidence interval; WBC, white blood cells; LDH, lactate dehydrogenase; AST, aspartate aminotransferase; ALT, alanine aminotransferase; TBIL, Total Bilirubin; DBIL, Direct Bilirubin; IBIL, indirect bilirubin; APTT, activated partial thromboplastin time; PT, prothrombin time; hs-CRP, high-sensitivity C-reactive protein; FBG, fasting blood glucose. A semiquantitative CT scoring system was designed to assess the involvement degree or area of pneumonia for each lung lobe (total 5 lung lobes): 0 for 0% involvement; 1 for 1--25% involvement; 2 for 26--50% involvement; 3 for 51--75% involvement; 4 for 76--100% involvement. A CT score (range, 0--20) was assigned by summarizing for the total scores of five lobes. CT images were reviewed independently by two radiologists with \>10 years of experience.
